Pillstats
Rx only · Tablet, Film Coated · Oral

Dipyridamole

Dipyridamole

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3521
US makers4 labelers
Packages28
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.077$0.153$0.230$0.307Dec 2025Apr 2026Jul 2026
$0.260
Latest avg · Jul 22, 2026
+8%
Since Dec 17, 2025
4
Active US suppliers
86%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

641281912552025 Q12025 Q22025 Q32025 Q42026 Q1
129
Rx · 2026 Q1
12K
Units dispensed
-40%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown12SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown12SUPPLYING
Oxford Pharmaceuticals, LLCunknown3SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.